{"protocolSection":{"identificationModule":{"nctId":"NCT01239628","orgStudyIdInfo":{"id":"A-48-52120-152"},"organization":{"fullName":"Ipsen","class":"INDUSTRY"},"briefTitle":"A Prospective, Non-interventional Survey to Evaluate Injection Intervals and Treatment Modalities of Botulinum Toxin A (BoNT-A) in Adult Patients Suffering From Upper Limb Spasticity After Stroke","officialTitle":"A National, Prospective, Non-interventional Survey to Evaluate Injection Intervals and Treatment Modalities up to 3 Years Follow up of Botulinum Toxin A in Adult Subjects Suffering From Upper Limb Spasticity Post-CVA (Cerebrovascular Accident)","acronym":"DECIDE"},"statusModule":{"statusVerifiedDate":"2020-03","overallStatus":"TERMINATED","whyStopped":"Participant enrolment was lower than expected","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2010-12"},"primaryCompletionDateStruct":{"date":"2015-12","type":"ACTUAL"},"completionDateStruct":{"date":"2015-12","type":"ACTUAL"},"studyFirstSubmitDate":"2010-11-10","studyFirstSubmitQcDate":"2010-11-10","studyFirstPostDateStruct":{"date":"2010-11-11","type":"ESTIMATED"},"lastUpdateSubmitDate":"2020-03-30","lastUpdatePostDateStruct":{"date":"2020-03-31","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Ipsen","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":false},"descriptionModule":{"briefSummary":"The purpose of the protocol is to evaluate injection intervals and treatment modalities up to 3 years follow-up of botulinum toxin A (BoNT-A) in adult patients suffering from upper limb spasticity after stroke."},"conditionsModule":{"conditions":["Upper Limb Spasticity After Stroke"]},"designModule":{"studyType":"OBSERVATIONAL","designInfo":{"observationalModel":"COHORT","timePerspective":"PROSPECTIVE"},"enrollmentInfo":{"count":45,"type":"ACTUAL"}},"outcomesModule":{"primaryOutcomes":[{"measure":"Documentation of the injection intervals","timeFrame":"3 years"},{"measure":"Documentation of treatment modalities","timeFrame":"3 years"}],"secondaryOutcomes":[{"measure":"Documentation of the main reason(s) for change in injection intervals","timeFrame":"3 years"},{"measure":"Documentation of the main reason(s) for dose change(s)","timeFrame":"3 years"},{"measure":"Documentation of the patient satisfaction with the treatment","timeFrame":"3 years"},{"measure":"Documentation of the physician satisfaction with the treatment","timeFrame":"3 years"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Subject able to comply with the protocol\n* Provision of written informed consent prior to collecting the data\n* Male or female patients of 18 years or older\n* Presenting with upper limb spasticity after stroke for which treatment with botulinum toxin A is indicated\n\nExclusion Criteria:\n\n* The subject has already been included in this survey\n* Patients who already received BoNT-A treatment for upper limb spasticity\n* Patients with known intolerance for BoNT-A\n* Subjects unable to comply with the protocol","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"Patients with a history of stroke, suffering from upper limb spasticity","samplingMethod":"NON_PROBABILITY_SAMPLE"},"contactsLocationsModule":{"overallOfficials":[{"name":"Medical Director, Neurology","affiliation":"Ipsen","role":"STUDY_DIRECTOR"}],"locations":[{"facility":"St- Augustinus","city":"Antwerpen","country":"Belgium","geoPoint":{"lat":51.21989,"lon":4.40346}},{"facility":"ZNA Middelheim","city":"Antwerpen","country":"Belgium","geoPoint":{"lat":51.21989,"lon":4.40346}},{"facility":"AZ St-Jan","city":"Brugge","zip":"8000","country":"Belgium","geoPoint":{"lat":51.20892,"lon":3.22424}},{"facility":"RevalidatieZiekenhuis RevArte","city":"Edegem","country":"Belgium","geoPoint":{"lat":51.15662,"lon":4.44504}},{"facility":"AZ Sint Lucas","city":"Gent","zip":"9000","country":"Belgium","geoPoint":{"lat":51.05,"lon":3.71667}},{"facility":"Revalidatiecentrum St Ursula","city":"Herk-de-Stad","country":"Belgium","geoPoint":{"lat":50.94013,"lon":5.16636}},{"facility":"ZOL, Campus Sint Barbara","city":"Lanaken","country":"Belgium","geoPoint":{"lat":50.89318,"lon":5.6468}},{"facility":"Heilig Hart Ziekenhuis","city":"Lier","country":"Belgium","geoPoint":{"lat":51.13128,"lon":4.57041}},{"facility":"HÃ´pital Marie Curie","city":"Lodelinsart","country":"Belgium","geoPoint":{"lat":50.43138,"lon":4.44886}},{"facility":"CHU Leonardo da Vinci","city":"Montigny-le-Tilleul","country":"Belgium","geoPoint":{"lat":50.38056,"lon":4.37582}},{"facility":"CHPLT Peltzer","city":"Verviers","country":"Belgium","geoPoint":{"lat":50.58907,"lon":5.86241}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000009128","term":"Muscle Spasticity"}],"ancestors":[{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000009135","term":"Muscular Diseases"},{"id":"D000009140","term":"Musculoskeletal Diseases"},{"id":"D000009122","term":"Muscle Hypertonia"},{"id":"D000020879","term":"Neuromuscular Manifestations"},{"id":"D000009461","term":"Neurologic Manifestations"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M11775","name":"Muscle Spasticity","asFound":"Spasticity","relevance":"HIGH"},{"id":"M11782","name":"Muscular Diseases","relevance":"LOW"},{"id":"M11787","name":"Musculoskeletal Diseases","relevance":"LOW"},{"id":"M11769","name":"Muscle Hypertonia","relevance":"LOW"},{"id":"M22309","name":"Neuromuscular Manifestations","relevance":"LOW"},{"id":"M12094","name":"Neurologic Manifestations","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC05","name":"Musculoskeletal Diseases"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]},"interventionBrowseModule":{"browseLeaves":[{"id":"M4873","name":"Botulinum Toxins","relevance":"LOW"},{"id":"M250157","name":"abobotulinumtoxinA","relevance":"LOW"},{"id":"M20947","name":"Botulinum Toxins, Type A","relevance":"LOW"},{"id":"M250251","name":"incobotulinumtoxinA","relevance":"LOW"}],"browseBranches":[{"abbrev":"All","name":"All Drugs and Chemicals"}]}},"hasResults":false}